Workshop: Ready, Set, Go : a new era in cervical cancer prevention for Australian GPs and their teams | Dr Lara Roeske, AProf Julia Brotherton (90 mins)
Tracks
State 2
| Friday, October 20, 2017 |
| 2:00 PM - 3:30 PM |
| State 2 |
Overview
The National Cervical Screening Program (NCSP) will move to 5-yearly HPV screening with partial genotyping for HPV16/18 for women aged 25-74 years. This session will ensure GPs are prepared to implement the new National Cervical Screening Program commencing on the 1st December 2017 under the new Guidelines (2016).
GPs play a key role in the prevention of cervical cancer in Australia. GPs are the largest providers of cervical screening services and play an important role in educating women about the benefits of participation in routine cervical screening.
This session will outline the evidence informing the review of the NCSP and discuss the impact and future directions of the National HPV Vaccination Program (NHVP).
An overview of key components of the new NCSP, including the self-collection pathway will assist GPs to implement the new program in practice. GPs will update cervical sampling technique, interpret a range of Cervical Screening Test (CST) results and review key management recommendations for asymptomatic and symptomatic women.
Learning outcomes from this session for attending GPs:
1. Explain the association between HPV and cervical cancer to a woman; 2. Demonstrate optimal collection and handling of cervical samples under the new program; 3. Interpret a range of Cervical Screening Test (CST) results and apply the correct management recommendations; 4. Confident to implement the new self-collection pathway, including identification of eligible women, explaining vaginal HPV self-sampling and follow-up.
(90 mins)
Speaker
AProf Julia Brotherton
Medical Director
Registries and Research
Workshop : Ready, Set, Go : a new era in cervical cancer prevention for GPs and their team.
Biography
Associate Professor Julia Brotherton, Medical Director, Registries and Research & Epidemiologist, Victorian Cytology Service Ltd.
GDip App Epi, B Med (Hons), MPH (Hons), FAFPHM, PhD, GAICD.
A/Prof Julia Brotherton is a public health physician and Medical Director of Australia’s National HPV Vaccination Program Register. For the past ten years Julia has been involved in research and policy development informing the implementation and evaluation of HPV vaccination programs in Australia. She has been a lead investigator in Australian research which has demonstrated the world’s first evidence of dramatic declines in both HPV infections and pre-cancerous cervical lesions in young women post-vaccination.
Dr Lara Roeske
GP & Liaison Physician
Workshop : Ready, Set, Go : a new era in cervical cancer prevention for GPs and their teams
Biography
Dr Lara Roeske, Liaison Physician, VCS Pathology and Chair RACGPSI Sexual Health Medicine Network
BSc (Hons), MBBS (Hons), DipVen (Monash), FRACGP.
Dr Lara Roeske is member of the Cancer Council Australia Cervical Cancer Screening Guidelines Working Party and a co-author of the 2016 National Cervical Screening Program: Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding.
In her role as VCS Liaison Physician Lara provides clinical management advice and conducts educational visiting services to support GPs and practice teams in the provision of high quality cervical screening services. Lara is a practice owner, and is Deputy Chair RACGP Victoria and RACGP Specific Interests.
